1. Home
  2. NOG vs NUVB Comparison

NOG vs NUVB Comparison

Compare NOG & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Oil and Gas Inc.

NOG

Northern Oil and Gas Inc.

HOLD

Current Price

$27.53

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$5.84

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOG
NUVB
Founded
2006
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
NOG
NUVB
Price
$27.53
$5.84
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$29.14
$11.44
AVG Volume (30 Days)
1.7M
4.0M
Earning Date
05-26-2026
01-01-0001
Dividend Yield
6.86%
N/A
EPS Growth
N/A
N/A
EPS
0.39
N/A
Revenue
$2,475,723,000.00
N/A
Revenue This Year
$18.95
$659.84
Revenue Next Year
N/A
$180.43
P/E Ratio
$23.85
N/A
Revenue Growth
11.23
N/A
52 Week Low
$19.88
$1.57
52 Week High
$32.62
$9.75

Technical Indicators

Market Signals
Indicator
NOG
NUVB
Relative Strength Index (RSI) 60.94 47.60
Support Level $26.50 $5.12
Resistance Level $28.24 $6.22
Average True Range (ATR) 1.15 0.33
MACD -0.03 0.09
Stochastic Oscillator 78.41 70.95

Price Performance

Historical Comparison
NOG
NUVB

About NOG Northern Oil and Gas Inc.

Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: